PubRank

Hans-Gustaf Ljunggren

Author PubWeight™ 138.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 2005 3.99
2 Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 2010 3.58
3 Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 2009 3.46
4 Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J Exp Med 2005 3.41
5 Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev 2006 3.30
6 Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling. Science 2004 3.08
7 Heat-shock proteins as activators of the innate immune system. Trends Immunol 2002 2.96
8 Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med 2010 2.89
9 Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood 2009 2.88
10 Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc Res 2003 2.44
11 Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients. Blood 2007 2.32
12 NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 2013 2.04
13 The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J 2006 2.04
14 Memory CD8+ T cells provide an early source of IFN-gamma. J Immunol 2003 1.93
15 KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression. Blood 2009 1.92
16 Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection. Gastroenterology 2010 1.85
17 CD1d-dependent activation of NKT cells aggravates atherosclerosis. J Exp Med 2004 1.80
18 Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines. Int Immunol 2002 1.66
19 Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. Blood 2009 1.62
20 Organ-specific features of natural killer cells. Nat Rev Immunol 2011 1.48
21 Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition. J Immunol 2004 1.46
22 DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells. Cancer Res 2007 1.45
23 Pillars article: Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 1989. 340: 443-448. J Immunol 2007 1.40
24 Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells. J Immunol 2009 1.38
25 NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy. J Immunol 2004 1.30
26 CD56 negative NK cells: origin, function, and role in chronic viral disease. Trends Immunol 2010 1.30
27 Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components. Blood 2008 1.28
28 Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment. J Immunol 2009 1.24
29 Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants. Nat Med 2006 1.17
30 Estimation of the size of the alloreactive NK cell repertoire: studies in individuals homozygous for the group A KIR haplotype. J Immunol 2008 1.17
31 Impact of FASL-induced apoptosis in the elimination of tumor cells by NK cells. Mol Immunol 2005 1.17
32 Different NK cell-activating receptors preferentially recruit Rab27a or Munc13-4 to perforin-containing granules for cytotoxicity. Blood 2009 1.16
33 Functional analysis of human NK cells by flow cytometry. Methods Mol Biol 2010 1.16
34 Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study. Immunotherapy 2009 1.14
35 NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation. Blood 2010 1.14
36 Natural killer and dendritic cell contact in lesional atopic dermatitis skin--Malassezia-influenced cell interaction. J Invest Dermatol 2002 1.12
37 The crystal structure of the major cat allergen Fel d 1, a member of the secretoglobin family. J Biol Chem 2003 1.11
38 Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kappaB inhibition. Proc Natl Acad Sci U S A 2004 1.11
39 Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production. Blood 2013 1.11
40 Natural killer cells in human autoimmunity. Curr Opin Immunol 2009 1.11
41 NK cells stimulate proliferation of T and NK cells through 2B4/CD48 interactions. J Immunol 2004 1.11
42 KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation. Mol Immunol 2005 1.10
43 Longitudinal analysis of the human T cell response during acute hantavirus infection. J Virol 2011 1.09
44 Application of nine-color flow cytometry for detailed studies of the phenotypic complexity and functional heterogeneity of human lymphocyte subsets. J Immunol Methods 2007 1.07
45 2B4/CD48-mediated regulation of lymphocyte activation and function. J Immunol 2005 1.07
46 NKG2D performs two functions in invariant NKT cells: direct TCR-independent activation of NK-like cytolysis and co-stimulation of activation by CD1d. Eur J Immunol 2011 1.05
47 Increased infection-related mortality in KIR-ligand-mismatched unrelated allogeneic hematopoietic stem-cell transplantation. Transplantation 2004 1.05
48 CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells. Blood 2012 1.04
49 Transmission of Toxoplasma gondii from infected dendritic cells to natural killer cells. Infect Immun 2009 1.01
50 Clinical presentation of Griscelli syndrome type 2 and spectrum of RAB27A mutations. Pediatr Blood Cancer 2010 1.01
51 Scrapie protein degradation by cysteine proteases in CD11c+ dendritic cells and GT1-1 neuronal cells. J Virol 2004 0.99
52 Invasion and persistence of the neuroadapted influenza virus A/WSN/33 in the mouse olfactory system. Viral Immunol 2003 0.98
53 Spotlight on IL-22-producing NK cell receptor-expressing mucosal lymphocytes. Nat Immunol 2009 0.98
54 Cytokine-induced killer T cells kill immature dendritic cells by TCR-independent and perforin-dependent mechanisms. J Leukoc Biol 2006 0.98
55 Activation of innate immunity, inflammation, and potentiation of DNA vaccination through mammalian expression of the TLR5 agonist flagellin. J Immunol 2005 0.97
56 Elevated numbers of Fc gamma RIIIA+ (CD16+) effector CD8 T cells with NK cell-like function in chronic hepatitis C virus infection. J Immunol 2008 0.96
57 Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D. Blood 2011 0.95
58 Tracing dynamic expansion of human NK-cell subsets by high-resolution analysis of KIR repertoires and cellular differentiation. Eur J Immunol 2014 0.95
59 Characterization of natural killer cell phenotype and function during recurrent human HSV-2 infection. PLoS One 2011 0.94
60 Processing and degradation of exogenous prion protein by CD11c(+) myeloid dendritic cells in vitro. J Virol 2002 0.94
61 Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1. J Infect Dis 2012 0.94
62 Escape from immune- and nonimmune-mediated tumor surveillance. Semin Cancer Biol 2005 0.93
63 Analysis of the KIR repertoire in human NK cells by flow cytometry. Methods Mol Biol 2010 0.93
64 Tumor cell recognition by the NK cell activating receptor NKG2D. Eur J Immunol 2008 0.93
65 Temporal dynamics of the primary human T cell response to yellow fever virus 17D as it matures from an effector- to a memory-type response. J Immunol 2013 0.92
66 NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy. Cancer Immunol Immunother 2008 0.92
67 Development and function of CD1d-restricted NKT cells: influence of sphingolipids, SAP and sex. Trends Immunol 2005 0.91
68 Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model. Exp Hematol 2007 0.91
69 Hantavirus-infection confers resistance to cytotoxic lymphocyte-mediated apoptosis. PLoS Pathog 2013 0.91
70 Spotlight on NKG2C and the human NK-cell response to CMV infection. Eur J Immunol 2012 0.91
71 Insights into NK cell biology from human genetics and disease associations. Cell Mol Life Sci 2011 0.90
72 2B4 co-stimulation: NK cells and their control of adaptive immune responses. Mol Immunol 2005 0.89
73 Efficient antigen presentation of soluble, but not particulate, antigen in the absence of Wiskott-Aldrich syndrome protein. Immunology 2003 0.89
74 Killer cell immunoglobulin-like receptor workshop: insights into evolution, genetics, function, and translation. Immunity 2011 0.88
75 Regulation of perforin-independent NK cell-mediated cytotoxicity. Eur J Immunol 2003 0.88
76 Kinome analysis of receptor-induced phosphorylation in human natural killer cells. PLoS One 2012 0.87
77 Excitotoxic neurodegeneration induced by intranasal administration of kainic acid in C57BL/6 mice. Brain Res 2002 0.87
78 Compromised function of natural killer cells in acute and chronic viral hepatitis. J Infect Dis 2013 0.86
79 Natural killer cell-mediated lysis of dorsal root ganglia neurons via RAE1/NKG2D interactions. Eur J Immunol 2003 0.86
80 Human cytomegalovirus-derived protein UL18 alters the phenotype and function of monocyte-derived dendritic cells. J Leukoc Biol 2007 0.86
81 Production, crystallization and preliminary crystallographic study of the major cat allergen Fel d 1. Acta Crystallogr D Biol Crystallogr 2003 0.86
82 Efficient gene transfer into primary human natural killer cells by retroviral transduction. Exp Hematol 2005 0.85
83 Effects on synaptic activity in cultured hippocampal neurons by influenza A viral proteins. J Neurovirol 2005 0.85
84 The critical role of IL-12p40 in initiating, enhancing, and perpetuating pathogenic events in murine experimental autoimmune neuritis. Brain Pathol 2002 0.84
85 Structural basis of the differential stability and receptor specificity of H-2Db in complex with murine versus human beta2-microglobulin. J Mol Biol 2005 0.83
86 Immune modulation by the human cytomegalovirus-encoded molecule UL18, a mystery yet to be solved. J Immunol 2008 0.83
87 Cannabinoids affect dendritic cell (DC) potassium channel function and modulate DC T cell stimulatory capacity. J Immunol 2008 0.83
88 Diversification and Functional Specialization of Human NK Cell Subsets. Curr Top Microbiol Immunol 2016 0.82
89 Natural killer cell-mediated lysis of freshly isolated human tumor cells. Int J Cancer 2009 0.82
90 Exogenous soluble tumor necrosis factor receptor type I ameliorates murine experimental autoimmune neuritis. Neurobiol Dis 2003 0.81
91 Immunomodulatory activity of commonly used drugs on Fc-receptor-mediated human natural killer cell activation. Cancer Immunol Immunother 2014 0.81
92 Three-dimensional structure of Fel d 1, the major allergen in cat. Int Arch Allergy Immunol 2003 0.80
93 CD4 and CD8 T cells, but not B cells, are critical to the control of murine experimental autoimmune neuritis. Exp Neurol 2002 0.80
94 IFN-gamma production dominates the early human natural killer cell response to Coxsackievirus infection. Cell Microbiol 2007 0.80
95 IL-12p35 deficiency alleviates kainic acid-induced hippocampal neurodegeneration in C57BL/6 mice. Neurobiol Dis 2004 0.80
96 Structural elements underlying the high binding affinity of human cytomegalovirus UL18 to leukocyte immunoglobulin-like receptor-1. J Mol Biol 2007 0.80
97 Neutralizing antibodies to IL-18 ameliorate experimental autoimmune neuritis by counter-regulation of autoreactive Th1 responses to peripheral myelin antigen. J Neuropathol Exp Neurol 2002 0.80
98 Dissection of the interaction of the human cytomegalovirus-derived US2 protein with major histocompatibility complex class I molecules: prominent role of a single arginine residue in human leukocyte antigen-A2. J Biol Chem 2006 0.80
99 Aggravation of experimental autoimmune neuritis in TNF-alpha receptor 1 deficient mice. J Neuroimmunol 2007 0.79
100 Natural killer cells: biology, physiology and medicine--part 1. J Innate Immun 2011 0.79
101 Reduced susceptibility to kainic acid-induced excitoxicity in T-cell deficient CD4/CD8(-/-) and middle-aged C57BL/6 mice. J Neuroimmunol 2004 0.79
102 Selenite induces posttranscriptional blockade of HLA-E expression and sensitizes tumor cells to CD94/NKG2A-positive NK cells. J Immunol 2011 0.79
103 Targeting IL-2 to the endoplasmic reticulum confines autocrine growth stimulation to NK-92 cells. Exp Hematol 2005 0.79
104 Kainic acid-induced excitotoxic hippocampal neurodegeneration in C57BL/6 mice: B cell and T cell subsets may contribute differently to the pathogenesis. Brain Behav Immun 2004 0.78
105 Natural killer cells: biology, physiology and medicine - part 2. J Innate Immun 2011 0.78
106 Lymphocyte effector functions: armed for destruction? Curr Opin Immunol 2007 0.78
107 Induction of protective CTL immunity against peptide transporter TAP-deficient tumors through dendritic cell vaccination. Cancer Res 2007 0.77
108 Increased susceptibility to experimental autoimmune neuritis after upregulation of the autoreactive T cell response to peripheral myelin antigen in apolipoprotein E-deficient mice. J Neuropathol Exp Neurol 2004 0.77
109 Unique features of NK cell development during ontogeny revealed in studies of RAG-1-deficient mice. Immunol Cell Biol 2009 0.77
110 Co-stimulatory molecules in islet xenotransplantation: CTLA4Ig treatment in CD40 ligand-deficient mice. Cell Transplant 2002 0.77
111 Göran Möller 1936-2008. Scand J Immunol 2008 0.76
112 Severe defect in thymic development in an insertional mutant mouse model. J Immunol 2007 0.76
113 Expression, refolding and crystallization of murine MHC class I H-2Db in complex with human beta2-microglobulin. Acta Crystallogr Sect F Struct Biol Cryst Commun 2005 0.76
114 Arrestin NK cell cytotoxicity. Nat Immunol 2008 0.76
115 2011 Nobel Prize in Physiology or Medicine to three immunologists. Scand J Immunol 2011 0.75
116 Dendritic cells, dendritic cell-based vaccines and Ralph Steinman. J Intern Med 2011 0.75